Long-term incidence of urinary tract infection after ureteral reimplantation for primary vesicoureteral reflux *

Size: px
Start display at page:

Download "Long-term incidence of urinary tract infection after ureteral reimplantation for primary vesicoureteral reflux *"

Transcription

1 Journal of Pediatric Urology (2013) 9, 92e98 Long-term incidence of urinary tract infection after ureteral reimplantation for primary vesicoureteral reflux * Caleb P. Nelson a, *, Katherine C. Hubert a,b, Paul J. Kokorowski a, Lin Huang c, Michaella M. Prasad a, Ilina Rosoklija a, Alan B. Retik a a Department of Urology, Hunnewell 390, Children s Hospital Boston, 300 Longwood Ave., Boston, MA 02115, USA b Harvard Pediatric Health Research Fellowship Program, Harvard Medical School, Boston, MA, USA c Clinical Research Program, Children s Hospital Boston, MA, USA Received 19 September 2011; accepted 16 December 2011 Available online 18 January 2012 KEYWORDS Vesicoureteral reflux; Ureteral reimplantation; Urinary tract infection; Pyelonephritis Abstract Objective: To determine the incidence of urinary tract infection (UTI) after ureteral reimplantation (UR) for primary vesicoureteral reflux (VUR). Materials and methods: In this retrospective review, the pyelonephritis-free survival of patients with primary VUR who underwent open UR from January 1990 to December 2002 was assessed using a Cox proportional hazards analysis. Results: 1076 patients underwent open UR for primary VUR. 73.0% were female; median age was 4.7 years. 80.1% presented with UTI. Clinical success rate for non-tapered UR was 96.5%. Median follow-up was 2.9 years. 21.8% had at least one postoperative UTI. 6.5% had postoperative pyelonephritis (POP) at a median of 21 months postoperatively. On multivariate survival analysis female gender (OR 9.97, 95% CI 3.07e32.34), preoperative VUR grade 3 (2.14, 1.25e3.69), breakthrough preoperative UTI (2.00, 1.22e3.25), and preoperative renal scarring (1.86, 1.15e2.99) were associated with POP. Conclusion: POP is rare on long-term follow-up, suggesting that UR is effective in reducing pyelonephritis in this population. ª 2011 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved. * Address for Clinical Research Program: 1 Autumn St., Boston, MA 02115, USA. * Corresponding author. Tel.: þ ; fax: þ addresses: caleb.nelson@childrens.harvard.edu (C.P. Nelson), katherine.hubert@childrens.havard.edu (K.C. Hubert), paul. kokorowski@childrens.harvard.edu (P.J. Kokorowski), lin.huang@childrens.harvard.edu (L. Huang), michaella.maloney@gmail.com (M.M. Prasad), ilina.rosoklija@childrens.harvard.edu (I. Rosoklija), alan.retik@childrens.harvard.edu (A.B. Retik) /$36 ª 2011 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved. doi: /j.jpurol

2 UTI after ureteral reimplantation for VUR 93 Introduction Among children with primary vesicoureteral reflux (VUR), breakthrough urinary tract infection (UTI) has long been considered a primary indication for anti-reflux procedures (ARPs) such as ureteral reimplantation (UR). In fact, reduction in incidence of febrile UTI is one of the only clinical benefits of UR that has been demonstrated in randomized controlled trials [1]. There are limited data, however, on the long-term incidence of UTI after UR, due to the focus in the literature on technical success of the ARP rather than the long-term clinical outcomes. The 10-year results of 252 children in the International Reflux Study in Children (IRSC) demonstrated a higher proportion of children who had acute pyeloenephritis in the medical group (25%) than in the surgical group (14%) (P < 0.03) [2]. Given the requirement for grade III or IV VUR and prior UTI for study entry, however, the results of the IRSC may not be generalizable to all patients undergoing UR for the correction of primary VUR [3]. More recently, the advent of endoscopic therapy for VUR has added a new option for children needing an ARP. As with open surgery, much of the debate has focused on the technical success, or lack thereof, of endoscopic therapy. However, it has also been claimed that the incidence of post- ARP UTI is significantly lower among children who undergo endoscopic ARP compared to those who undergo UR [4]. One shortcoming of such a comparison between highly selected, non-randomized groups of patients is the fact that confounding factors such as VUR grade and a prior history of breakthrough UTIs may explain the difference between groups. The purpose of this study was to perform a retrospective review of the long-term clinical outcome after UR for primary VUR, with a particular focus on the incidence of UTI. Materials and methods We performed a retrospective chart review of records of patients who underwent UR at our institution between January 1990 and December Our surgical database was developed via analysis of billing records (to identify cases) and medical records (to identify patient characteristics and outcomes). A hospital billing database was queried to identify all UR procedures performed during the designated timeframe. The billing codes used were CPT codes 50780, 50782, 50783, and the ICD-9 code Data were collected from electronic records and departmental and hospital paper charts. Institutional Review Board approval was obtained for this study. The inclusion criteria were patients undergoing open UR for primary VUR (radiographic grade IeV or scintigraphic grade 1e3). Primary VUR was defined as isolated VUR in the absence of other congenital or acquired anatomic or neurogenic abnormalities of the lower urinary tract. Patients with functional issues of elimination (e.g. dysfunctional voiding ) were not excluded from the primary VUR group. Indications for surgery in patients with primary VUR included breakthrough UTI, persistent VUR, change in differential renal function, development of new renal cortical scarring, parental preference or non-compliance with antibiotic therapy. Both intravesical and extravesical UR procedures were included. We excluded all patients undergoing UR for secondary VUR (that is, VUR associated with neural tube defects or other causes of neurogenic bladder, posterior urethral valves, bladder exstrophy, renal transplant, prune belly syndrome, or ureterocele) as well as repeat procedures, laparoscopic procedures, and endoscopic procedures. Preoperative VUR was graded based on the final cystogram prior to UR using the IRSC system [5]. In cases of bilateral VUR, grade was based on the worse side. When the final preoperative cystogram was a radionuclide cystogram (RNC) graded on a 1e3 scale, we used the following system to convert the RNC grade to the IRSC system: RNC grade 1 Z IRSC grade I, RNC grade 2 Z IRSC grade 2, and RNC grade 3 Z IRSC grade 4 [6]. Other patient variables recorded included gender, race/ethnicity, age at surgery, clinical presentation, occurrence of breakthrough UTI during the preoperative period, and the presence of renal scarring on imaging. Breakthrough UTI was defined as a non-febrile or febrile, culture-proven UTI while on antimicrobial prophylaxis. Renal scarring was defined as the presence of echogenic foci indicating scarring on at least one renal ultrasound and/or the presence of one or more cortical defects on at least one DMSA scan. Procedure variables included intravesical versus extravesical approach, need for ureteral tailoring (tapered or excised), and reimplantation of a single system versus a completely duplicated system (classified as duplicated if at least one duplicated system reimplanted). The primary outcome was incidence of clinical pyelonephritis during the postoperative period based on evidence in the medical record. This was defined as a culture-proven UTI involvingone or more organisms, with fever (defined as a temperature of at least 38.5 C) and/or flank pain and/or acute phase renal scintigraphy documenting evidence of acute infection. Patients whose chart indicated a diagnosis of pyelonephritis without documentation of fever were included in the group with postoperative pyelonephritis (POP). We also analyzed as a secondary outcome any UTI, defined as a non-febrile or febrile UTI with associated urinary symptoms (dysuria, frequency, suprapubic pain), confirmed by culture. The outcome variable any UTI was also based on evidence in the medical record. The number of colony-forming units (CFU) required for diagnosis of a UTI was 50,000 for catheterized specimens and 100,000 for clean-catch voided specimens. Surgical outcomes were strict technical success defined as absence of VUR on postoperative cystogram within 6 months of UR. It is not uncommon, however, for patients to have minimal or trace grade 1 VUR on their postoperative cystogram, which is likely of minimal clinical significance. Therefore, we also performed our analyses using a secondary outcome called clinical technical success which included either absent VUR or grade 1 VUR on the postoperative cystogram within 6 months of UR. Surgical outcomes were only assessed among those who underwent routine postoperative screening, since inclusion of those unscreened patients who did eventually undergo VCUG would introduce a strong selection bias because those patients had a clinical indication for VCUG. The success rate among this group therefore may not be representative of overall surgical outcomes; these data were therefore excluded from assessment of surgical outcomes.

3 94 C.P. Nelson et al. Bivariate and multivariable analyses were carried out using SAS software (SAS Institute, Cary, NC). Comparison of means was achieved using t-tests and ANOVA. Individual categorical variables were tested for associations using Chisquare tests. The primary outcome (pyelonephritis-free survival) was analyzed using Cox proportional hazards analysis, with multivariable models used to control for multiple independent variables. Significance level of 0.05 was applied for hypothesis testing. Results Of 1466 overall UR procedures, 1076 (73.4%) were for primary VUR, and this group represented the sample for analysis. The key patient and procedure characteristics are shown in Table 1. Most patients were female, and the median age was 4.7 years; 37.3% were grade 1e2, 19% were grade 3, 43.7% were grade 4e5. Clinical presentation was UTI in a large majority (80.1%). Of the 290 males in the study, 145 (50%) presented with UTI and of those 34 (23.5%) had at least one preoperative breakthrough UTI. An additional 11 males also had at least one preoperative breakthrough UTI. Of the 596 patients with grades IIIeIV VUR, 316 (53%) presented with a febrile UTI and of those 60 (10%) also had a preoperative breakthrough febrile UTI. Of the total 1076 patients, 382 (35.5%) had at least one preoperative DMSA scan; of those, renal scarring was noted in 63.1% (241/382). Extravesical UR was performed in 18.5%, intravesical UR in 81.5%. Ureteral tapering was required in 99 patients (8.7%). The strict technical success rate was high. Among the 846 patients who had a cystogram within 6 months of surgery (Table 1), the strict technical success rate (i.e. absence of VUR on cystogram) was 93.5%. The clinical technical success rate (i.e. either absent VUR or grade I-VUR on cystogram), was 95.3%. Finally, if UR procedures that required ureteral tailoring are excluded, the clinical technical success rate was 96.5%. Median follow-up was 2.9 years (range: 0e6.9 years) and mean follow-up was 3.4 years. Many patients continued to be seen for a number of years after UR: 29.6% had follow-up >5-years, 71.7% had more than 1 year of follow-up, 56.3% had more than 2 years, 49.1% had more than 3 years, and 37.9% had more than 4 years. Overall, the incidence of any postoperative UTI was 21.8% (Table 2). Most of these patients were diagnosed either due to lower urinary tract symptoms (dysuria, frequency, etc.) or via screening cultures. The median time to initial postoperative UTI was 8.7 months. Only eight patients had a postoperative UTI, two of them febrile, within the first 2 months following reimplantation. Of the 235 patients who had any postoperative UTI (febrile or nonfebrile), 77 (35.7%) of them were on antibiotic prophylaxis at the time of the infection. Only 70 (6.5%) patients developed clinical pyelonephritis during the postoperative period (Table 2). Pyelonephritis tended to occur significantly later in the postoperative course than did cystitis; the median time from UR to initial postoperative pyelonephritis (POP) episode was 21.3 months (range of 20 days to 4.0 years). Of the 1076 patients, 463 (43.0%) never developed either a preoperative or a postoperative febrile UTI. Of the 596 patients with grade IIIeIV VUR, 46 (7.7%) developed clinical pyelonephritis during the Table 1 Variable Patient and procedure characteristics. N Patient characteristics Age at surgery (years) Mean (SD) 5.06 (3.61) Median 4.67 Race/ethnicity White 560 (52.4%) Hispanic 45 (4.2%) Black 7 (0.7%) Native American/Alaskan 1 (0.1%) Asian 17 (1.6%) Other 3 (0.3%) Unknown/missing 443 (41.2%) Gender Male 290 (27.0%) Female 786(73%) VUR grade at last cystogram (highest side) 1 17 (1.6%) (35.7%) (19.0%) (38.0%) 5 60 (5.7%) VUR laterality Unilateral left 307 (28.5%) Unilateral right 175 (16.3%) Bilateral 593 (55.2%) Clinical presentation Febrile UTI 590 (54.9%) Non-febrile UTI 271 (25.2%) Prenatal hydronephrosis 122 (11.4%) Sibling screen 44 (4.1%) Incidental 12 (1.1%) Other 35 (3.3%) Preoperative breakthrough UTI Yes 398 (37.1%) No 676 (62.9%) Preoperative renal scarring Yes 341 (31.7%) No 735 (68.3%) Procedure characteristics Bladder approach Intravesical 875 (81.5%) Extravesical 198 (18.5%) Laterality Unilateral left 307 (28.5%) Unilateral right 175 (16.3%) Bilateral 593 (55.2%) Ureteral tailoring Non-tapered 976 (91.3%) Tapered 93 (8.7%) Duplication status Duplicated renal collecting system 205 (19.1%) Single renal collecting system 870 (80.9%) Postoperative cystogram within 6 months Yes 846 (78.6%) No 230 (21.4%) (continued on next page)

4 UTI after ureteral reimplantation for VUR 95 Table 1 (continued) Variable 6 month technical success Overall No VUR 791 (93.5%) Grade 1 15 (1.8%) Grade 2 40 (4.7%) Tapered UR No VUR 63 (78.8%) Grade 1 4 (5.0%) Grade 2 13 (16.2%) Non-tapered UR No VUR 723 (95.0%) Grade 1 11 (1.5%) Grade 2 27 (3.5%) postoperative period. Using Cox proportional hazards analysis we analyzed factors that were associated with POP-free survival (Table 3). On bivariate analysis, significant factors included female gender, presentation with UTI, breakthrough preoperative UTI, and presence of renal scarring. Higher grade VUR (3) was a marginally significant factor associated with POP-free survival. Although there was a trend toward patients with strict technical success having a lower incidence of POP, this was not statistically significant. Age, bladder approach (extravesical versus intravesical), unilateral versus bilateral, and ureteral tailoring were not associated with POP. On multivariate analysis (Table 3), the factors significantly associated with lower POP-free survival, after controlling for other factors, included high VUR grade, female gender, history of breakthrough UTI, and preoperative scarring. Table 4 shows the predicted 5-year POP-free survival after UR, based on the findings of the multivariate Cox model. As can be seen, males are highly unlikely to develop POP, while females are much more likely to do so, particularly those with higher grade, breakthrough UTI history, and/or scarring. The far higher propensity of females to develop POP with increasing time after UR is demonstrated graphically in a KaplaneMeier curve (Fig. 1). Discussion The primary goal of this study was to determine the incidence of UTI after UR performed for primary VUR. We found Table 2 Postoperative UTI and pyelonephritis. Initial postoperative UTI None 841 (78.2%) UTI: febrile 44 (4.1%) UTI: non-febrile, symptomatic 75 (7.0%) UTI: non-febrile asymptomatic 59 (5.5%) UTI: non-febrile (symptomatic status unknown) 33 (3.1%) UTI: febrile status unknown 24 (2.2%) Median time to initial UTI 8.7 months Postoperative pyelonephritis Yes 70 (6.5%) No 1006 (93.5%) Median time to pyelonephritis 21.3 months N that, with extended follow-up, POP is relatively uncommon with only about 6% of patients diagnosed. Any UTI, febrile or not, is relatively common, with over 20% of patients diagnosed. There is surprisingly little literature describing the longterm clinical outcomes after UR. In the IRSC, the incidence of UTI over a 5-year period following surgery was 39%, while clinical pyelonephritis occurred in 10% [7]. As a randomized trial this study might be considered the gold standard, but the IRSC results are only generalizable to children with dilating VUR (IRSC grade IIIeIV). In another long-term, retrospective study of patients 10-years after UR, Beetz et al. found that, among the 83.5% of patients they could contact, 17% had experienced postoperative febrile UTI [8]. The VUR grades in this cohort spanned a wider range, with w40% of renal units having IRSC grade III [8]. In contrast to these high rates of POP, Whittam et al. reported in a recent series that of 395 patients who underwent UR febrile UTI was diagnosed in just 4.6%, although the followup time was relatively short at a mean of 15 months [9]. The low incidence of postoperative UTI (21.6%) and POP (6.4%) in our study may be due to differences in the patient populations given that our cohort included patients with all grades of VUR. In fact, higher grade VUR (3) was shown in our multivariate analysis to be associated with significantly lower POP-free survival. In our study, even patients with the same grades of VUR (IIIeIV) as those included in the IRSC had a lower incidence of POP (7.7%) than the patients in the IRSC [10]. The current series is one of the largest reported of longterm UTI outcomes across a broad cross-section of VUR patients undergoing UR. Furthermore, this is the only study to analyze postoperative UTI using a multivariate survival analysis that takes into account the varying follow-up periods seen in the study sample. Such variation in length of follow-up is inherent in retrospective reviews, but most prior articles have analyzed incidence of UTI as a simple categorical variable, rather than accounting for time to event. Whittam et al. did perform time to event analysis of possible predictors of febrile UTI following UR but theirs was limited to univariate testing [9]. In a more recent report comparing open UR with results after endoscopic ARP, Elmore et al. reported that postoperative febrile UTI occurred in 24.1% of the children after UR versus just 5% of children after endoscopic ARP [4]. However, this was a highly selected, non-randomized sample, and the preoperative breakthrough UTI rate was almost twice as high in the UR group as the endoscopic group (21% vs 10%). There are likely other confounding factors, and no multivariate analysis was performed to adjust for recognized factors that might contribute to POP (e.g. VUR grade, breakthrough UTI). There is strong evidence that nonrandomized (or poorly randomized) treatment allocation introduces significant bias into a study [10]. The hypothesis generated by a study such as the one by Elmore et al. is fascinating: does open UR disrupt host defense factors significantly more than endoscopic treatment? Without a randomized controlled trial we may never be certain; in the meantime, we must be careful in assessing the relative merits of various ARPs. There has been much recent discussion about whether the availability of endoscopic ARP should alter the indications for

5 96 C.P. Nelson et al. Table 3 Multivariate analysis of POP-free survival. Variable Hazard ratio P-value Multivariate hazard ratio Multivariate p-value VUR grade (0.98, 2.88) (1.25, 3.69) Female gender 9.90 (3.12, 31.15) (3.07,32.34) Age 0.96 (0.89e1.03) e e Duplex system 0.78 (0.41e1.48) e e Laterality and bladder approach e e Extravesical e Unilateral intravesical 0.81 (0.41e1.57) Bilateral intravesical 0.76 (0.41e1.39) Ureteral tapering 0.55 (0.20e1.50) e e Initial clinical presentation 0.01 e e Other (did not present with UTI) e Non-febrile UTI 3.07 (0.60e15.83) Febrile UTI 3.99 (1.59e10.05) Technical success at 6 months e e No postoperative imaging within 6 months e No reflux 1.15 (0.57e2.34) Reflux 1.98 (0.74e5.32) Breakthrough preoperative UTI 2.60 (1.61e4.19) < (1.22e3.25) Preoperative renal scarring 1.62 (1.01e2.59) (1.15e2.99) the procedure. Suggestions have appeared in the literature that endoscopic treatment should be utilized as initial therapy for patients diagnosed with VUR. Advocates argue that immediate endoscopic therapy is preferable to antimicrobial prophylaxis in children just diagnosed with VUR [11]. Current standards of care do not yet embrace such early treatment, and the available data make it clear that immediate ARP (using any method) makes little sense, since the only demonstrated benefit of ARP is prevention of recurrent febrile UTI, and a majority of newly diagnosed patients with VUR (except those with high-grade VUR) will never experience arecurrentfebrileuti[12,13]. Therefore,analgorithmthat directs all newly diagnosed VUR patients into immediate surgical treatment (even if it is the low morbidity endoscopic ARP) is destined to treat large numbers of children for whom there will not be measurable benefits. The results of our study support the idea that there are subsets of patients that may be predisposed to pyelonephritis after UR. On multivariate analysis, the factors in our study that were significantly associated with lower POP-free survival included high VUR grade, female gender, history of breakthrough UTI, and preoperative renal scarring. Our findings confirm those of the recently published Swedish reflux study which found that girls with high-grade VUR had a significantly higher rate of recurrent febrile UTIs than boys [14]. Although this study does not support any change in the indications for surgery, it documents a low rate of POP among all children who undergo reimplantation. There are probably benefits of surgery even among the subgroups that are more likely to have POP. Even among this high-risk group, however, the risk is relatively low, as our nomogram shows (Table 4). A randomized trial would be required to show if reimplantation reduces the risk of POP in this highrisk group specifically. Several authors have similarly concluded that preoperative breakthrough UTIs are also a risk factor for postoperative UTI following endoscopic ARP [15e17]. This brings into question whether patients with a history of preoperative breakthrough UTIs should be placed in a different category in terms of follow-up and counseling after either endoscopic ARP or UR. Table 4 Nomogram showing the predicted 5-year POP-free survival after UR. VUR grade Breakthrough Preop. renal Pyelonephritis-free survival (95% CI) preop. UTI scar Male Female 1e2 No No 99.6% (99.1%, 100%) 96.0% (93.6%, 98.4%) Yes 99.2% (98.3%, 100%) 92.7% (88.2%, 97.4%) Yes No 99.2% (98.1%, 100%) 92.2% (88.1%, 96.5%) Yes 98.5% (96.6%, 100%) 86.0% (78.6%, 94.1%) 3 No No 99.1% (98.1%, 100%) 91.6% (87.7%, 95.6%) Yes 98.4% (96.5%, 100%) 84.9% (78.2%, 92.3%) Yes No 98.3% (96.1%, 100%) 84.0% (77.8%, 90.6%) Yes 96.8% (93.1%, 100%) 72.3% (62.6%, 83.4%)

6 UTI after ureteral reimplantation for VUR 97 Funding source Dr. Hubert is supported by the Harvard Pediatric Health Services Research Fellowship Program and by grant number T32eHS from the Agency for Healthcare Research and Quality (AHRQ), National Research Service Award (NRSA). Dr. Kokorowski is supported by grant number T32-DK60442 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Nelson is supported by grant number K23-DK from NIDDK. The study sponsors had no involvement in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication. Figure 1 Pyelonephritis-free survival after ureteral reimplantation. There are certain limitations of this study that should be acknowledged. As a retrospective series it is subject to all of the recognized weaknesses of this methodology including selection bias and loss to follow-up. For example, outcome events that occurred subsequent to a patient s last encounter at our facility would not have been included. As noted above, we sought to control for the varying length of follow-up by using a survival analysis. Another weakness is that we could not adjust for the presence of dysfunctional elimination syndrome (DES) in our data. Although we sought in the initial data collection to do so, we found quickly that the many definitions of dysfunctional voiding used by a variety of clinicians in the study, as well as the varying treatments instituted for this, resulted in a clinical condition that was impossible to meaningfully define from a research standpoint. We recognize the clinical significance of DES in VUR, and several studies have found that DES is a significant risk factor for UTI after UR. However, we found that the I know it when I see it quality of DES rendered a strict definition impossible, and it became clear that any variable we developed would be little better than arbitrary. Although DES is not accounted for in the retrospective analysis, it is our practice to evaluate all patients with VUR for the presence of the syndrome and treat them accordingly prior to consideration of any anti-reflux procedures. This should limit the potential misclassification of a patient as having primary VUR when in fact he or she has secondary VUR. Conclusions Although some children experience UTI after UR, the incidence of postoperative clinical pyelonephritis is very low, even on very long-term follow-up. Given that most of these patients initially present with pyelonephritis, these findings support the contention that UR is effective in reducing the incidence of pyelonephritis in this population. Ethical approval This study was approved by the Institutional Review Board. Conflict of interest statement The authors do not have any conflicts of interest. Acknowledgments The authors wish to acknowledge the following for their clinical and research contributions to this study: Anthony Atala, MD, Stuart Bauer, MD, Joseph Borer, MD, Marc Cendron, MD, Bartley Cilento, Jr., MD, MPH, David Diamond, MD, Sarah Dobbins, MPH, Carlos Estrada, MD, Irina Kasarskis, MPH, Richard Lee, MD, James Mandell, MD, Hiep Nguyen, MD, Melanie Pennison, MPH, and Craig Peters, MD. References [1] Hodson E, Wheeler D, Vimalchandra D, Smith GH, Craig JC. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev; 2007:CD [2] Jodal U, Smellie JM, Hildegard L. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. final report of the International Reflux Study in Children. Pediatr Nephrol 2006;21:785e92. [3] Weiss R, Tamminen-Mobius T, Koskimies O, Obling H, Smellie JM, Hirche H, et al. Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter international therapeutic trial comparing medical and surgical management. J Urol 1992;148:1644e9. [4] Elmore JM, Kirsch AJ, Heiss EA, Gilchrist A, Scherz HC. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation. J Urol 2008;179: 2364e8. [5] Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics 1981;67:392e400. [6] Willi U, Treves S. Radionuclide voiding cystography. Urol Radiol 1983;5:161e73. [7] Jodal U, Koskimies O, Hanson E, Lohr G, Obling H, Smellie J, et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. The International Reflux Study in Children. J Urol 1992;148:1650e2. [8] Beetz R, Mannhardt W, Fisch M, Stein R, Thuroff JW. Longterm follow-up of 158 young adults surgically treated for vesicoureteral reflux in childhood: the ongoing risk of urinary tract infections. J Urol 2002;168:704e7.

7 98 C.P. Nelson et al. [9] Whittam BM, Thomasch JR, Makari JH, Tanaka S, Thomas JC, Pope JC, et al. Febrile urinary tract infection after ureteroneocystostomy: a contemporary assessment at a single institution. J Urol 2010;183:688e92. [10] Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408e12. [11] Dawrant MJ, Mohanan N, Puri P. Endoscopic treatment for high grade vesicoureteral reflux in infants. J Urol 2006;176:1847e50. [12] Garin EH, Olavarria F, Garcia NV, Valenciano B, Campos A, Young L, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626e32. [13] Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R, et al. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179e86. [14] Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S, et al. The Swedish reflux trial in children: III. urinary tract infection pattern. J Urol 2010;184: 286e91. [15] Chi A, Gupta A, Snodgrass W. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2008;179:1966e9. [16] Sedberry-Ross S, Rice DC, Pohl HG, Belman B, Majd M, Rushton HG, et al. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. J Urol 2008;180:1605e10. [17] Traxel E, DeFoor W, Reddy P, Sheldon C, Minevich E. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. J Urol 2009;182:1708e13.

Topic 1 - Management of vesicoureteral reflux in the child over one year of age

Topic 1 - Management of vesicoureteral reflux in the child over one year of age Topic 1 - Management of vesicoureteral reflux in the child over one year of age Contents Index patient... 2 Introduction... 2 Methodology... 3 Initial evaluation of the Child with VUR... 4 Continuous Antibiotic

More information

Medical Policy Title: Periureteral Bulking ARBenefits Approval: 10/26/201

Medical Policy Title: Periureteral Bulking ARBenefits Approval: 10/26/201 Medical Policy Title: Periureteral Bulking ARBenefits Approval: 10/26/201 Agents as a Treatment of Vesicoureteral Reflux (VUR) Effective Date: 01/01/2012 Document: ARB0278 Revision Date: Code(s): 52327

More information

Medical Management of childhood UTI and VUR. Dr Patrina HY Caldwell Paediatric Continence Education, CFA 15 th November 2013

Medical Management of childhood UTI and VUR. Dr Patrina HY Caldwell Paediatric Continence Education, CFA 15 th November 2013 Medical Management of childhood UTI and VUR Dr Patrina HY Caldwell Paediatric Continence Education, CFA 15 th November 2013 Terminology According to the current ICCS terminology guidelines Bladder and

More information

Salvage Dextranomer-Hyaluronic Acid Copolymer for Persistent Reflux After Ureteral Reimplantation: Early Success Rates

Salvage Dextranomer-Hyaluronic Acid Copolymer for Persistent Reflux After Ureteral Reimplantation: Early Success Rates Vesicoureteral Reflux Salvage Dextranomer-Hyaluronic Acid Copolymer for Persistent Reflux After Ureteral Reimplantation: Early Success Rates Yuval Bar-Yosef,* Miguel Castellan, Devandra Joshi, Andrew Labbie

More information

The Evolving Role of Antibiotic Prophylaxis for Vesicoureteral Reflux. Stephen Canon, MD Children s Urology

The Evolving Role of Antibiotic Prophylaxis for Vesicoureteral Reflux. Stephen Canon, MD Children s Urology The Evolving Role of Antibiotic Prophylaxis for Vesicoureteral Reflux Stephen Canon, MD Children s Urology www.childrensurology.com May 17, 2008 Objectives Review literature establishing the value of antibiotic

More information

Vesicoureteral Reflux: The Difficulty of Consensus OR Why Can t We All Just get Along?

Vesicoureteral Reflux: The Difficulty of Consensus OR Why Can t We All Just get Along? Vesicoureteral Reflux: The Difficulty of Consensus OR Why Can t We All Just get Along? J Brandt MD MPH Pediatric Nephrology, UNMSOM Family Practice Grand Rounds 2/14/2012 Why do we worry about VUR? 3

More information

Cortical renal scan in febrile UTI: Established usefulness and future developments

Cortical renal scan in febrile UTI: Established usefulness and future developments Cortical renal scan in febrile UTI: Established usefulness and future developments Diego De Palma, MD Nuclear Medicine, Circolo Hospital, Varese, Italy UTI is common in the pediatric population! Girls

More information

Vesicoureteral Reflux (VUR) New

Vesicoureteral Reflux (VUR) New Vesicoureteral Reflux (VUR) New What is vesicoureteral reflux? Vesicoureteral reflux is the abnormal backflow of urine from the bladder into the ureter and up to the kidney. The majority of the time this

More information

ARTICLE. Disappearance of Vesicoureteral Reflux in Children

ARTICLE. Disappearance of Vesicoureteral Reflux in Children Disappearance of Vesicoureteral Reflux in Children Martin Wennerström, MD; Sverker Hansson, MD, PhD; Ulf Jodal, MD, PhD; Eira Stokland, MD, PhD ARTICLE Objective: To describe the disappearance of reflux

More information

Secondary surgery for vesicoureteral reflux after failed endoscopic injection: Comparison to primary surgery

Secondary surgery for vesicoureteral reflux after failed endoscopic injection: Comparison to primary surgery Original Article - Pediatric Urology pissn 2466-0493 eissn 2466-054X Secondary surgery for vesicoureteral reflux after failed endoscopic injection: Comparison to primary surgery Seungsoo Lee, Seung Chan

More information

Pediatric urinary tract infection. Dr. Nariman Fahmi Pediatrics/2013

Pediatric urinary tract infection. Dr. Nariman Fahmi Pediatrics/2013 Pediatric urinary tract infection Dr. Nariman Fahmi Pediatrics/2013 objectives EPIDEMIOLOGY CAUSATIVE PATHOGENS PATHOGENESIS CATEGORIES OF URINARY TRACT INFECTIONS AND CLINICAL MANIFESTATIONS IN pediatrics

More information

Why is the management of UTI so controversial? Kjell Tullus Consultant Paediatric Nephrologist

Why is the management of UTI so controversial? Kjell Tullus Consultant Paediatric Nephrologist Why is the management of UTI so controversial? Kjell Tullus Consultant Paediatric Nephrologist Diagnosing a UTI More difficult then most people realise Contaminating culture Bacterial numbers Confusion

More information

Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup

Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup Eugene K. Lee,* John M. Gatti, Romano T. DeMarco and J. Patrick Murphy From

More information

Long-Term Clinical Follow up of Children with Primary Vesicoureteric Reflux. C.K. Abeysekara, B.M.C.D. Yasaratna and A.S.

Long-Term Clinical Follow up of Children with Primary Vesicoureteric Reflux. C.K. Abeysekara, B.M.C.D. Yasaratna and A.S. Brief Reports Long-Term Clinical Follow up of Children with Primary Vesicoureteric Reflux C.K. Abeysekara, B.M.C.D. Yasaratna and A.S.Abeyagunawardena From the Department of Pediatrics, Faculty of Medicine,

More information

UTI and VUR Practical points and management Kjell Tullus Consultant Paediatric Nephrologist

UTI and VUR Practical points and management Kjell Tullus Consultant Paediatric Nephrologist UTI and VUR Practical points and management Kjell Tullus Consultant Paediatric Nephrologist Discussion points Diagnosis VUR Radiological investigations 1. Contamination Problems 2. Bacterial numbers 3.

More information

Review Article Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?

Review Article Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today? Hindawi Publishing Corporation Advances in Urology Volume 2008, Article ID 217805, 5 pages doi:10.1155/2008/217805 Review Article Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux:

More information

Indications and effectiveness of the open surgery in vesicoureteral reflux

Indications and effectiveness of the open surgery in vesicoureteral reflux Indications and effectiveness of the open surgery in vesicoureteral reflux Suzi DEMIRBAG, MD Department of Pediatric Surgery, Gulhane Military Medical Academy, Ankara, TURKEY Vesicoureteral reflux (VUR)

More information

Recurrent Pediatric UTI Revisited 2013

Recurrent Pediatric UTI Revisited 2013 Recurrent Pediatric UTI Revisited 2013 PIDSP 21.2.2013 Shai Ashkenazi, MD, MSc Medicine changes constantly Some aspects of the standard practice of ~40 years are probably not valid and need to be changed

More information

Clinical Value of Persistent but Downgraded Vesicoureteral Reflux after Dextranomer/Hyaluronic Acid Injection in Children

Clinical Value of Persistent but Downgraded Vesicoureteral Reflux after Dextranomer/Hyaluronic Acid Injection in Children ORIGINL RTICLE Urology http://dx.doi.org/1.3346/jkms.13.28.7.16 J Korean Med Sci 13; 28: 16-164 Clinical Value of Persistent but Downgraded Vesicoureteral Reflux after Dextranomer/Hyaluronic cid Injection

More information

Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux. Original Policy Date

Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux. Original Policy Date MP 7.01.82 Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature

More information

Surgical Intervention for Vesicoureteric Reflux Change Management

Surgical Intervention for Vesicoureteric Reflux Change Management Surgical Intervention for Vesicoureteric Reflux Change Management Dr. Michael P. Leonard Professor of Surgery and Pediatrics CHEO / University of Ottawa Objectives 1. To review the previously accepted

More information

Editorial. A Changing Scenario in Our Understanding of Vesicoureteral Reflux in Children

Editorial. A Changing Scenario in Our Understanding of Vesicoureteral Reflux in Children Editorial A Changing Scenario in Our Understanding of Vesicoureteral Reflux in Children In this issue of the Journal is an article on the long-term clinical outcome of primary vesicoureteral reflux (VUR)

More information

PYELONEPHRITIS. Wendy Glaberson 11/8/13

PYELONEPHRITIS. Wendy Glaberson 11/8/13 PYELONEPHRITIS Wendy Glaberson 11/8/13 A 19mo infant girl was seen in the ED 3 days ago and diagnosed with a UTI. She was afebrile at the time and discharged on broad spectrum antibiotics. The child returns

More information

10. Diagnostic imaging for UTI

10. Diagnostic imaging for UTI 10. Diagnostic imaging for UTI Key question: What is the most effective imaging test for the diagnosis of structural abnormalities of the urinary tract and/or kidney damage in children with UTI? Current

More information

16.1 Risk of UTI recurrence in children

16.1 Risk of UTI recurrence in children 16. UTI prognosis 16.1 Risk of UTI recurrence in children Key question: What is the risk of recurrent UTI in children with no known structural or functional abnormalities of the urinary tract with a first

More information

Topic 2: Management of infants less than one year of age with vesicoureteral reflux

Topic 2: Management of infants less than one year of age with vesicoureteral reflux Topic 2: Management of infants less than one year of age with vesicoureteral reflux Contents Index patient... 2 Introduction... 2 Methodology... 3 Outcomes Analysis... 3 Summary... 8 References... 11 Copyright

More information

B. W. Palmer, M. Hemphill, K. Wettengel, B. P. Kropp, and D. Frimberger

B. W. Palmer, M. Hemphill, K. Wettengel, B. P. Kropp, and D. Frimberger SAGE-Hindawi Access to Research International Nephrology Volume 2011, Article ID 276308, 5 pages doi:10.4061/2011/276308 Research Article The Value of Cystography in Detecting De Novo and Residual Vesicoureteral

More information

Topic 5: Screening of the neonate/infant with prenatal hydronephrosis

Topic 5: Screening of the neonate/infant with prenatal hydronephrosis Topic 5: Screening of the neonate/infant with prenatal hydronephrosis Contents Index patient... 2 Introduction... 2 Methodology... 2 Outcomes Analysis... 3 Summary... 11 References... 12 Copyright 2010

More information

Urinary Tract Infections in Infants & Toddlers: An Evidence-based Approach. No disclosures. Importance of Topic 5/14/11. Biases

Urinary Tract Infections in Infants & Toddlers: An Evidence-based Approach. No disclosures. Importance of Topic 5/14/11. Biases Urinary Tract Infections in Infants & Toddlers: An Evidence-based Approach Thomas B. Newman, MD, MPH Professor of Epidemiology & Biostatistics and Pediatrics University of California, San Francisco May

More information

Comparison of Renal Ultrasound and Voiding Cystourethrography in the Detection of Vesicoureteral Reflux. Sedigheh Ebrahimi

Comparison of Renal Ultrasound and Voiding Cystourethrography in the Detection of Vesicoureteral Reflux. Sedigheh Ebrahimi GMJ. 2013;2(2):54-59 Comparison of Renal Ultrasound and Voiding Cystourethrography in the Detection of Vesicoureteral Reflux Sedigheh Ebrahimi Department of Pediatrics, Department of Medical Ethics, Shiraz

More information

Urinary tract infections, renal malformations and scarring

Urinary tract infections, renal malformations and scarring Urinary tract infections, renal malformations and scarring Yaacov Frishberg, MD Division of Pediatric Nephrology Shaare Zedek Medical Center Jerusalem, ISRAEL UTI - definitions UTI = growth of bacteria

More information

The Role of Endoscopic Treatment in the Management of Grade V Primary Vesicoureteral Reflux

The Role of Endoscopic Treatment in the Management of Grade V Primary Vesicoureteral Reflux european urology 52 (2007) 1505 1510 available at www.sciencedirect.com journal homepage: www.europeanurology.com Pediatric Urology The Role of Endoscopic Treatment in the Management of Grade V Primary

More information

Description. Section: Surgery Effective Date: April 15, Subsection: Surgery Original Policy Date: December 6, 2012 Subject:

Description. Section: Surgery Effective Date: April 15, Subsection: Surgery Original Policy Date: December 6, 2012 Subject: Last Review Status/Date: March 2015 Page: 1 of 11 Description Vesicoureteral reflux (VUR) is the retrograde flow of urine from the bladder upward toward the kidney and is most commonly seen in children.

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme Clinical guideline CG54: Urinary tract infection: diagnosis, treatment and long-term management of

More information

Predicting Factors of Breakthrough Infection in Children with Primary Vesicoureteral Reflux

Predicting Factors of Breakthrough Infection in Children with Primary Vesicoureteral Reflux Original Article http://dx.doi.org/10.3349/ymj.2012.53.4.748 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 53(4):748-752, 2012 Predicting Factors of Breakthrough Infection in Children with Primary Vesicoureteral

More information

VESICOURETERAL REFLUX SCREENING IN SIBLINGS OF PATIENTS WITH KNOWN REFLUX

VESICOURETERAL REFLUX SCREENING IN SIBLINGS OF PATIENTS WITH KNOWN REFLUX VESICOURETERAL REFLUX SCREENING IN SIBLINGS OF PATIENTS WITH KNOWN REFLUX N. Ataei *1, A. Madani 1, S. T. Esfahani 1, A. Kejbafzadeh 2, M. Kamali 1 and A. Safa 1 1) Department of Pediatric Nephrology,

More information

Urinary tract infection in small children: the evolution of renal damage over time

Urinary tract infection in small children: the evolution of renal damage over time Pediatr Nephrol (2017) 32:1907 1913 DOI 10.1007/s00467-017-3705-5 ORIGINAL ARTICLE Urinary tract infection in small children: the evolution of renal damage over time Svante Swerkersson 1 & Ulf Jodal 1

More information

Vesicoureteral Reflux (VUR) in Children Where are we in 2014?

Vesicoureteral Reflux (VUR) in Children Where are we in 2014? Vesicoureteral Reflux (VUR) in Children Where are we in 2014? Kurt Eeg MD, FAAP Pediatric Urologist Sanford Children s Hospital Clinical Assistant Professor Department of Surgery and Pediatrics University

More information

Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children

Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children Craig A. Peters, Steven J. Skoog, Billy S. Arant, Jr., Hillary L. Copp, Jack S. Elder, R. Guy Hudson, Antoine E.

More information

Protocol. Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux

Protocol. Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux Protocol Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (701102) Medical Benefit Effective Date: 10/01/14 Next Review Date: 11/19 Preauthorization No Review Dates: 09/10, 09/11, 09/12,

More information

Hasan Serkan Dogan, Ali Cansu Bozaci, Burhan Ozdemir, Senol Tonyali, Serdar Tekgul

Hasan Serkan Dogan, Ali Cansu Bozaci, Burhan Ozdemir, Senol Tonyali, Serdar Tekgul ORIGINAL ARTICLE Vol. 40 (4): 539-545, July. August, 2014 doi: 10.1590/S1677-5538.IBJU.2014.04.14 Ureteroneocystostomy in primary vesicoureteral reflux: critical retrospective analysis of factors affecting

More information

How to Predict the Development of Severe Renal Lesions in Children with febrile UTI?

How to Predict the Development of Severe Renal Lesions in Children with febrile UTI? How to Predict the Development of Severe Renal Lesions in Children with febrile UTI? Constantinos J. Stefanidis Head of Pediatric Nephrology P. & A. Kyriakou Children s Hospital, Athens, Greece Long term

More information

Can Procalcitonin Reduce Unnecessary Voiding Cystoureterography in Children with First Febrile Urinary Tract Infection?

Can Procalcitonin Reduce Unnecessary Voiding Cystoureterography in Children with First Febrile Urinary Tract Infection? Original Article Iran J Pediatr Aug 2014; Vol 24 (No 4), Pp: 418-422 Can Procalcitonin Reduce Unnecessary Voiding Cystoureterography in Children with First Febrile Urinary Tract Infection? Aliasghar Halimi-asl,

More information

Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection

Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection Constantinos J. Stefanidis Head of Pediatric Nephrology P. & A. Kyriakou Children s Hospital, Athens,

More information

Treatment of a 6-Year-Old Girl with Vesicoureteral Reflux

Treatment of a 6-Year-Old Girl with Vesicoureteral Reflux T h e n e w e ngl a nd j o u r na l o f m e dic i n e C l i n i c a l D e c i s i o n s Interactive at nejm.org Treatment of a 6-Year-Old Girl with Vesicoureteral Reflux This interactive feature addresses

More information

Giovanni Montini has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

Giovanni Montini has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Giovanni Montini has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Imaging in Pediatric UTI Giovanni Montini Milano, Italy giovanni.montini@unimi.it

More information

Outcome of Vesicoureteral Reflux in Infants: Impact of Prenatal Diagnosis

Outcome of Vesicoureteral Reflux in Infants: Impact of Prenatal Diagnosis Original Article Iran J Pediatr Aug 2013; Vol 23 (No 4), Pp: 439-444 Outcome of Vesicoureteral Reflux in Infants: Impact of Prenatal Diagnosis Hamid Mohammadjafari* 1, MD; Alireza Alam 2, MD; Saeed Mohammadi

More information

UTI Update: Have We Been Led Astray? Disclosure. Objectives

UTI Update: Have We Been Led Astray? Disclosure. Objectives UTI Update: Have We Been Led Astray? KAAP Sept 28, 2012 Robert Wittler, MD 1 Disclosure Neither I nor any member of my immediate family has a financial relationship or interest with any entity related

More information

UTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys.

UTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys. UTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys. 1-3% of Below 1 yr. male: female ratio is 4:1 especially among uncircumcised males,

More information

Prescribing Guidelines for Urinary Tract Infections

Prescribing Guidelines for Urinary Tract Infections Prescribing Guidelines for Urinary Tract Infections Urinary Tract Infections in Children Urinary tract infections (UTIs) are common infections of childhood that may affect any part of the urinary tract,

More information

Audit of Micturating Cystourethrograms performed over 1 year in a Children's Hospital

Audit of Micturating Cystourethrograms performed over 1 year in a Children's Hospital Audit of Micturating Cystourethrograms performed over 1 year in a Children's Hospital Poster No.: C-1773 Congress: ECR 2012 Type: Scientific Exhibit Authors: K. Lyons, J. Sorensen, E. L. Twomey, V. Donoghue,

More information

Nicolette Janzen, MD Texas Children's Hospital

Nicolette Janzen, MD Texas Children's Hospital Which UTIs Need a VCUG? Applying AAP Guidelines Nicolette Janzen, MD Texas Children's Hospital Goals 1 2 3 4 5 Review the guidelines Present clinical scenarios Discuss VCUG and nuclear cystogram Discuss

More information

Role of Imaging Modalities in the Management of Urinary Tract Infection in Children

Role of Imaging Modalities in the Management of Urinary Tract Infection in Children Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/182 Role of Imaging Modalities in the Management of Urinary Tract Infection in Children M S Vinodkumar 1, M Vishnu

More information

5. Epidemiology of UTI and its complications in children

5. Epidemiology of UTI and its complications in children 5. Epidemiology of UTI and its complications in children Urinary tract infection (UTI) is one of the most frequent bacterial infections in infants and young children. Its incidence is influenced by age

More information

Current Trends in Pediatric GU Imaging European Perspective

Current Trends in Pediatric GU Imaging European Perspective Current Trends in Pediatric GU Imaging European Perspective Pierre-Hugues Vivier, MD, PhD CHU C. Nicolle, Rouen, France Générale de Santé, Hôpital Privé de l Estuaire, Le Havre, France 1.6% of boys / 7.8%

More information

Nursing Care for Children with Genitourinary Dysfunction I

Nursing Care for Children with Genitourinary Dysfunction I Nursing Care for Children with Genitourinary Dysfunction I 1 Assessment of renal function Clinical manifestations Laboratory tests Urinalysis Urine culture and sensitivity Renal/bladder ultrasound Testicular

More information

URINARY TRACT INFECTIONS Mark Schuster, M.D., Ph.D.

URINARY TRACT INFECTIONS Mark Schuster, M.D., Ph.D. - 351-20. URINARY TRACT INFECTIONS Mark Schuster, M.D., Ph.D. This review is based on textbooks of pediatrics (Roth and Gonzales in Oski et al., 1994), pediatric primary care ( ), and pediatric infectious

More information

Positional installation of contrast (PIC) and Redo-PIC cystography for diagnosis of occult vesicoureteral reflux

Positional installation of contrast (PIC) and Redo-PIC cystography for diagnosis of occult vesicoureteral reflux The Turkish Journal of Pediatrics 2018; 60: 180-187 DOI: 10.24953/turkjped.2018.02.010 Original Positional installation of contrast (PIC) and Redo-PIC cystography for diagnosis of occult vesicoureteral

More information

Protocol. Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux

Protocol. Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux Protocol Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (701102) Medical Benefit Effective Date: 10/01/14 Next Review Date: 11/18 Preauthorization Yes Review Dates: 09/10, 09/11, 09/12,

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

giovanni.montini@aosp.bo.it UTI - EPIDEMIOLOGY INCIDENCE: 1.7/1000 boys/year 3.1/1000 girls/year PREVALENCE: girls 6-7 % (0-6 y) boys 2-2,5 % (Jodal ESPN 2002) Fig 2 Distribution by age (months) and sex

More information

Antimicrobial Prophylaxis. for Children with Vesicoureteral. The RIVUR Trial Investigators* ABSTRACT

Antimicrobial Prophylaxis. for Children with Vesicoureteral. The RIVUR Trial Investigators* ABSTRACT The new england journal of medicine established in 1812 june 19, 2014 vol. 370 no. 25 Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux The RIVUR Trial Investigators* ABSTRACT Background

More information

P. Brandstrom has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

P. Brandstrom has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. P. Brandstrom has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Prophylaxis or not? Per Brandström Queen Silvia Children s Hospital Gothenburg

More information

Abnormal Dimercaptosuccinic Acid Scan May Be Related to Persistence of Vesicoureteral Reflux in Children with Febrile Urinary Tract Infection

Abnormal Dimercaptosuccinic Acid Scan May Be Related to Persistence of Vesicoureteral Reflux in Children with Febrile Urinary Tract Infection www.kjurology.org http://dx.doi.org/10.111/kju.2012.3.10.71 Pediatric Urology Abnormal Dimercaptosuccinic Acid Scan May Be Related to Persistence of Vesicoureteral Reflux in Children with Febrile Urinary

More information

URINARY TRACT INFECTION IN CHILDREN UNDERGOING DIAGNOSTIC VOIDING CYSTOURETHROGRAPHY

URINARY TRACT INFECTION IN CHILDREN UNDERGOING DIAGNOSTIC VOIDING CYSTOURETHROGRAPHY ORIGINAL ARTICLE URINARY TRACT INFECTION IN CHILDREN UNDERGOING DIAGNOSTIC VOIDING CYSTOURETHROGRAPHY ABSTRACT KHEMCHAND N MOORANI, JAI PARKASH, MAHESH KUMAR LOHANO Objective Study design Place & Duration

More information

ESTIMATES OF CUMULATIVE INCIdence

ESTIMATES OF CUMULATIVE INCIdence ORIGINAL CONTRIBUTION Recurrent Urinary Tract Infections in Children Risk Factors and Association With Prophylactic Antimicrobials Patrick H. Conway, MD, MSc Avital Cnaan, PhD Theoklis Zaoutis, MD, MSCE

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR) Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Periureteral Bulking Agents

More information

Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR)

Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR) Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux (VUR) Policy Number: 7.01.102 Last Review: 5/2018 Origination: 5/2006 Next Review: 5/2019 Policy Blue Cross and Blue Shield of Kansas

More information

Hydronephrosis. Nephrosis. Refers to the kidney

Hydronephrosis. Nephrosis. Refers to the kidney What is hydronephrosis? Hydro Nephrosis Refers to water or fluid Refers to the kidney A build-up of fluid (urine) in the kidney is the medical term for a build-up of urine in the kidney. As the urine builds

More information

Urinary tract infection. Mohamed Ahmed Fouad Lecturer of pediatrics Jazan faculty of medicine

Urinary tract infection. Mohamed Ahmed Fouad Lecturer of pediatrics Jazan faculty of medicine Urinary tract infection Mohamed Ahmed Fouad Lecturer of pediatrics Jazan faculty of medicine Objectives To differentiate between types of urinary tract infections To recognize the epidemiology of UTI in

More information

Vesicoureteric reflux in children

Vesicoureteric reflux in children Original Article Vesicoureteric reflux in children Jameela A Kari, Sherif M El Desoky, Faten Basnawi, Ohood Bahrawi Department of Pediatrics, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

More information

Technical Report Diagnosis and Management of an Initial UTI in Febrile Infants and Young Children

Technical Report Diagnosis and Management of an Initial UTI in Febrile Infants and Young Children FROM THE AMERICAN ACADEMY OF PEDIATRICS Technical Report Diagnosis and Management of an Initial UTI in Febrile Infants and Young Children S. Maria E. Finnell, MD, MS, Aaron E. Carroll, MD, MS, Stephen

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Vesicoureteral Reflux, Treatment with Periureteral Bulking Agents File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vesicoureteral_reflux_treatment_with_periureteral_bulking_agents

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Robinson, J, et al. and the Canadian Pediatric Society. Urinary tract infection in infants and children: Diagnosis and management. Pediatr Child Health 2014;

More information

Is antibiotic prophylaxis of any use in nephro-urology? Giovanni Montini Pediatric Nephrology and Dialysis Unit University of Milan Italy

Is antibiotic prophylaxis of any use in nephro-urology? Giovanni Montini Pediatric Nephrology and Dialysis Unit University of Milan Italy Is antibiotic prophylaxis of any use in nephro-urology? Giovanni Montini Pediatric Nephrology and Dialysis Unit University of Milan Italy UTI_VUR Bacteria and Humans: diverse behaviours!! Bacteria Humans

More information

Recurrent urinary tract infections in young children: Role of DMSA scan for detecting vesicoureteric reflux

Recurrent urinary tract infections in young children: Role of DMSA scan for detecting vesicoureteric reflux Recurrent urinary tract infections in young children: Role of DMSA scan for detecting vesicoureteric reflux Poster No.: C-2294 Congress: ECR 2014 Type: Authors: Keywords: DOI: Scientific Exhibit M. Awais,

More information

UTIs in children ( with controversies ) By Dr. Lindokuhle Mahlase

UTIs in children ( with controversies ) By Dr. Lindokuhle Mahlase UTIs in children ( with controversies ) By Dr. Lindokuhle Mahlase Epidemiology By age 7 years, 8 % of girls and 2 % of boys will have had a UTI. Most infections occur in the first 2 years of life ; boys

More information

The relationship between urinary tract infection and calcium excretion in children

The relationship between urinary tract infection and calcium excretion in children The Turkish Journal of Pediatrics 2012; 54: 387-392 Original The relationship between urinary tract infection and calcium excretion in children Ayça Altıncık 1, Ferah Sönmez 2, Nevin Semerci 2, Çiğdem

More information

Research Article Surgical Reimplantation for the Correction of Vesicoureteral Reflux following Failed Endoscopic Injection

Research Article Surgical Reimplantation for the Correction of Vesicoureteral Reflux following Failed Endoscopic Injection Advances in Urology Volume 2011, Article ID 352716, 5 pages doi:10.1155/2011/352716 Research Article Surgical Reimplantation for the Correction of Vesicoureteral Reflux following Failed Endoscopic Injection

More information

Urinary tract infection (UTI) is a common problem. In

Urinary tract infection (UTI) is a common problem. In Renal Infection and Vesico-Ureteric Reflux Monica A. Rossleigh, MBBS (Hons), MD, FRACP Urinary tract infection (UTI) is a common disease of childhood. The investigation of UTI in children has been the

More information

Pediatric Urinary Tract Infections

Pediatric Urinary Tract Infections Pediatric Urinary Tract Infections Sarmistha B. Hauger M.D. Pediatric Infectious Diseases Specially For Children Dell Children s Medical Center of Central Texas CME Conference 5/08 Pediatric UTI Epidemiology

More information

UTI and VUR practical points and management

UTI and VUR practical points and management UTI and VUR practical points and management Søren Rittig, Prof., DMSc Child and Adolescent Medicine, Aarhus University Hospital Aarhus, Denmark Outline Definition and diagnosis of UTI Treatment of UTI

More information

Technetium Tc 99m Dimercaptosuccinic Acid Renal Scintigraphy in Children With Acute Pyelonephritis Correlation With Other Imaging Tests

Technetium Tc 99m Dimercaptosuccinic Acid Renal Scintigraphy in Children With Acute Pyelonephritis Correlation With Other Imaging Tests Kidney Diseases Technetium Tc 99m Dimercaptosuccinic Acid Renal Scintigraphy in Children With Acute Pyelonephritis Correlation With Other Imaging Tests Masoumeh Mohkam, Saiid Maham, Afrand Rahmani, Ilana

More information

Urinary Tract Infections in Children: What We Know and What We Don t

Urinary Tract Infections in Children: What We Know and What We Don t Urinary Tract Infections in Children: What We Know and What We Don t Daniel Hirselj, MD Northwest Urology, LLC North Pacific Pediatric Society Conference April 29, 2017 Urinary Tract Infections in Children:

More information

Case Based Urology Learning Program

Case Based Urology Learning Program Case Based Urology Learning Program Resident s Corner: UROLOGY Case Number 23 CBULP 2011 077 Case Based Urology Learning Program Editor: Associate Editors: Manager: Case Contributors: Steven C. Campbell,

More information

UWE Bristol. UTI in Children. Angie Green Visiting Lecturer March 2011

UWE Bristol. UTI in Children. Angie Green Visiting Lecturer March 2011 UWE Bristol UTI in Children Angie Green Visiting Lecturer March 2011 Approx 2% children will develop acute febrile UTI Up to 10% girls will develop any kind of UTI Progressive scarring in children with

More information

Prenatal Hydronephrosis

Prenatal Hydronephrosis Prenatal Hydronephrosis What is hydronephrosis? Hydronephrosis is dilation of the kidney, specifically the renal pelvis (place where urine is stored after its production). This can be the result of an

More information

Imaging in Urinary Tract Infectioin

Imaging in Urinary Tract Infectioin Case Report Jawa, ZM Oniyangi, O Ononiwu, UN Imaging in Urinary Tract Infectioin Corresponding Author ( ) Jawa, Zabah Muhammad Department of Nuclear Medicine / Radiology National Hospital Abuja, Nigeria

More information

Urine Blockage in Newborns

Urine Blockage in Newborns Urine Blockage in Newborns National Kidney and Urologic Diseases Information Clearinghouse What is the urinary tract? The urinary tract is the body s drainage system for removing wastes and extra fluid.

More information

A STUDY ON LONGTERM OUTCOMES OF POSTERIOR URETHRAL VALVES

A STUDY ON LONGTERM OUTCOMES OF POSTERIOR URETHRAL VALVES 3 Original article A STUDY ON LONGTERM OUTCOMES OF POSTERIOR URETHRAL VALVES Dr. Urvish R. Parikh [1], Dr Sudhir B. Chandana [], Dr Vinay M. Rohra [3],, Dr Jay B. Pandya [5], Dr Ankit B. Kothari [4] Assistant

More information

Analysis of Uropathogens of Febrile Urinary Tract Infection in Infant and Relationship with Vesicoureteral Reflux

Analysis of Uropathogens of Febrile Urinary Tract Infection in Infant and Relationship with Vesicoureteral Reflux Original Article ISSN 2465-8243(Print) / ISSN: 2465-8510(Online) https://doi.org/10.14777/uti.2018.13.3.58 Urogenit Tract Infect 2018;13(3):58-65 http://crossmark.crossref.org/dialog/?doi=10.14777/uti.2018.13.3.58&domain=pdf&date_stamp=2018-12-25

More information

Managing Vesicoureteral Reflux in the Pediatric Patient: a Spectrum of Treatment Options for a Spectrum of Disease

Managing Vesicoureteral Reflux in the Pediatric Patient: a Spectrum of Treatment Options for a Spectrum of Disease Curr Treat Options Peds (2016) 2:23 34 DOI 10.1007/s40746-016-0042-z Pediatric Urology (P Reddy and B VanderBrink, Section Editors) Managing Vesicoureteral Reflux in the Pediatric Patient: a Spectrum of

More information

children with urinary tract infection

children with urinary tract infection Archives of Disease in Childhood, 1981, 56, 593-600 Effect of vesicoureteric reflux on renal growth in children with urinary tract infection JEAN M SMELLIE, DAVID EDWARDS, I C S NORMAND, AND NINA PRESCOD

More information

Uroradiology For Medical Students

Uroradiology For Medical Students Uroradiology For Medical Students Lesson 4: Cystography & Urethrography - Part 2 American Urological Association Review Cystography is useful in evaluating the bladder, the urethra and the competence of

More information

MICTURATING CYSTOURETHROGRAPHY- A PICTORIAL ESSAY

MICTURATING CYSTOURETHROGRAPHY- A PICTORIAL ESSAY PICTORIAL REVIEW MICTURATING CYSTOURETHROGRAPHY- A PICTORIAL ESSAY Palle Lalitha, 1 M. Ch. Balaji Reddy, 1 K. Jagannath Reddy, 1 Vijaya Kumari 2 1 2 Department of Radiology, Focus Diagnostic Center, Punjagutta,

More information

6 Page Male Incontinence Booklet 10/09/ :44 Page 1. The Natural Non-Surgical Option for Male Urinary Incontinence

6 Page Male Incontinence Booklet 10/09/ :44 Page 1. The Natural Non-Surgical Option for Male Urinary Incontinence 6 Page Male Incontinence Booklet /9/ :44 Page The Natural Non-Surgical Option for Male Urinary Incontinence 6 Page Male Incontinence Booklet /9/ :44 Page Stress Urinary Incontinence - A Stressful Prospect

More information

An update on the management of urinary tract infection. Citation Hong Kong Practitioner, 1997, v. 19 n. 3, p

An update on the management of urinary tract infection. Citation Hong Kong Practitioner, 1997, v. 19 n. 3, p Title An update on the management of urinary tract infection Author(s) Chan, TM Citation Hong Kong Practitioner, 1997, v. 19 n. 3, p. 137-141 Issued Date 1997 URL http://hdl.handle.net/10722/45038 Rights

More information

A study of primary megaureter Our experience

A study of primary megaureter Our experience Original Research Article A study of primary megaureter Our experience DVS Ramakrishna Prasad *, Srinivas S Department of Urology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India

More information